Fig. 2From: Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancerFSTL1 was overexpressed in GC tissues and associated with worse prognosis. a–e Relationship between FSTL1 mRNA expression and tumor stage or differentiation. f The protein expression of FSTL1 in GC patients. g The FSTL1 staining score in GC patients. h The expression pattern of FSTL1 in GC patients analyzed by immunohistochemistry (IHC). i Representative FSTL1-positive/negative staining in cancerous and adjacent normal tissues. j The overall survival curve of FSTL1+/− in GC patients. FSTL1 follistatin-like 1, N0 GC patients with no lymph node metastasis, Nx GC patients with lymph node metastasis, N normal, T tumorBack to article page